Manualised Cognitive–Behavioural Therapy in the Intensive Treatment of Adolescent Obsessive–Compulsive Disorder

2006 ◽  
Vol 23 (3) ◽  
pp. 200-220 ◽  
Author(s):  
Danay Savva ◽  
Clare Rees

AbstractThis article offers a preliminary investigation of the delivery of an intensive version of manualised cognitive–behavioural therapy for adolescent obsessive–compulsive disorder (OCD). The aim was to address issues of treatment accessibility within the area, including a shortage of therapists who feel competent and possess the expertise to successfully deliver these protocols. Two male adolescents, with a principal diagnosis of OCD, participated in eight weekly 150-minute sessions. A series of diagnostic, symptom severity, global functioning, and self-report measures were completed at pretreatment, across treatment weeks, at posttreatment, and at 6-week follow-up. Further, monitoring of multiple baselines across behaviours for each adolescent across treatment weeks served to extend results beyond mere end points. Process issues specific to each adolescent, his family, and the therapeutic relationship were considered. Along with the overall outcome results, such information aimed to provide useful data for clinicians interested in implementing the program. Reductions in OCD symptomology and symptom severity for both participants at posttreatment and at 6-week follow-up suggest that an intensive format of treatment delivery might benefit some adolescents.

Author(s):  
Ian Li ◽  
Michael Millard ◽  
Hila Haskelberg ◽  
Megan Hobbs ◽  
John Luu ◽  
...  

Abstract Background: The impacts of COVID-19 for people with obsessive-compulsive disorder (OCD) may be considerable. Online cognitive behavioural therapy (iCBT) programmes provide scalable access to psychological interventions, although the effectiveness of iCBT for OCD during COVID-19 has not been evaluated. Aim: This study investigated the uptake and effectiveness of iCBT for OCD (both self- and clinician-guided courses) during the first 8 months of the pandemic in Australia (March to October 2020) and compared outcomes with the previous year. Method: 1,343 adults (824/1343 (61.4%) female, mean age 33.54 years, SD = 12.00) commenced iCBT for OCD (1061 during the pandemic and 282 in the year before) and completed measures of OCD (Dimensional Obsessive-Compulsive Scale) and depression (Patient Health Questionaire-9) symptom severity, psychological distress (Kessler-10), and disability (WHO Disability Assessment Schedule) pre- and post-treatment. Results: During COVID-19, there was a 522% increase in monthly course registrations compared with the previous year, with peak uptake observed between April and June 2020 (a 1191% increase compared with April to June 2019). OCD and depression symptom severity were similar for the COVID and pre-COVID groups, although COVID-19 participants were more likely to enrol in self-guided courses (versus clinician-guided). In both pre- and during-COVID groups, the OCD iCBT course was associated with medium effect size reductions in OCD (g = 0.65–0.68) and depression symptom severity (g = 0.56–0.65), medium to large reductions in psychological distress (g = 0.77–0.83) and small reductions in disability (g = 0.35–.50). Conclusion: Results demonstrate the considerable uptake of online psychological services for those experiencing symptoms of OCD during COVID-19 and highlight the scalability of effective digital mental health services.


2014 ◽  
Vol 204 (1) ◽  
pp. 77-78 ◽  
Author(s):  
David Mataix-Cols ◽  
Cynthia Turner ◽  
Benedetta Monzani ◽  
Kayoko Isomura ◽  
Caroline Murphy ◽  
...  

SummaryA partial N-methyl-d-aspartate agonist, d-cycloserine, enhances fear extinction when given before or shortly after exposure to feared stimuli in animals. In this pilot double-blind placebo-controlled trial (trial number: ISRCTN70977225), 27 youth with obsessive–compulsive disorder were randomised to either 50mg d-cycloserine or placebo administered immediately after each of ten cognitive–behavioural therapy (CBT) sessions, primarily consisting of exposure and ritual prevention. Both groups improved significantly and maintained their gains at 1-year follow-up, with no significant advantage of d-cycloserine over placebo at any time point. The effects of CBT may not be augmented or accelerated when d-cycloserine is administered after sessions.


2013 ◽  
Vol 42 (3) ◽  
pp. 374-378 ◽  
Author(s):  
Kristen Hagen ◽  
Stian Solem ◽  
Bjarne Hansen

Background: Obsessive-compulsive disorder (OCD) has been observed in a substantial proportion of patients with schizophrenia. Although cognitive-behavioural therapy (CBT) is well documented for OCD, few case studies are available regarding CBT for comorbid OCD in schizophrenia. Aims: The study aims to present a case study to augment the limited knowledge concerning CBT treatment for OCD in patients with schizophrenia. Method: The research adopted a case study approach, with a baseline condition and repeated assessments during the 3-week treatment and 6-month follow-up period. Results: The treatment was successful and the patient achieved clinical significant change in OCD symptoms. The patient had a reduction on the Y-BOCS from 24 to 5 (79%) and from 38 to 10 (73%) on the OCI-R from before treatment to 6 months follow-up. He did not fulfil the criteria for an OCD diagnosis at the end of the 3-week treatment period, or the follow-up at 3- and 6 months. Conclusions: The results strengthen the impressions given by previous case studies suggesting that CBT may be a promising treatment for OCD in patients with schizophrenia.


Sign in / Sign up

Export Citation Format

Share Document